Jointly funded by the Texas Emerging Technology Fund (ETF) and the University of Texas (UT) is establishing research laboratories in three UT campuses: UT Health Science Center at Houston (UTHealth), UT M.D. Anderson Cancer Center (MDACC), and UT-Austin (UTA). TTI faculties will coordinate their research activities to provide the necessary inter-institutional infrastructure to advance drug discovery and development in the State of Texas. TTI faculties will establish independent, complementary, and collaborative  translational drug discovery programs.

Faculty

Zhiqiang An, PhD, Professor and Director

Qingyun (Jim) Liu, PhD, Professor

Xin (Alex) Ge, PhD, Professor

Wenliang Li, PhD, Associate Professor

Kyoji Tsuchikama, PhD, Associate Professor

Ningyang Zhang, PhD, Associate Professor

Dr. Clifford Stephan, Assistant Professor